Connect with George Kouvas
George has long experience in industrial environments where he brought complex systems to market. He is passionate about helping the community bring technical innovations to life with the goal to improve the lives of people with nervous system disorders.
George Kouvas joined the Wyss Center in February 2017 and was appointed as CTO in January 2020. With over 20 years of experience in medical devices, neurotechnology, pharma, eHealth, eBusiness and R&D services, Kouvas holds a Diploma in Electrical and Computer Engineering and an MBA, from the National Technical University of Athens (NTUA).
Under his leadership, one of the Wyss Center’s flagship programs, EPIOS™ sub-scalp brain monitoring system, evolved from an initial idea to an investable technology to be validated in clinical settings.
George enjoys reviewing and evaluating technology innovation projects and proposals.
Prior to joining the Wyss Center, he was a Director and Technical leader of Merck’s eHealth platform in Switzerland, where he managed the development and market-launch of disease management solutions for several therapeutic areas. Earlier in his career he held various engineering and management roles, coordinating consortiums of technology, business and academia partners in innovation projects.
Subscribe to our updates
Wyss Center partners with Artiria Medical to accelerate a novel therapy for cerebral vasospasm
The new device will interact with the nerves responsible for constriction of brain arteries - a common complication after hemorrhagic stroke.Collaboration
The Wyss Center announces CE mark for its brain-computer interface software for communication, NeuroKey BCI
NeuroKey BCI enables people who are completely locked-in to communicate in real time.Technology
Epios™ selected for MassChallenge Switzerland 2021 accelerator
The Wyss Center’s spin-off company Epios joins a global network of entrepreneurs with its long-term brain monitoring technology.Technology